BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6270486)

  • 1. Improved high-affinity binding of 3H-apomorphine with a subcellular membrane fraction of mammalian brain tissue.
    Arana GW; Baldessarini RJ; Herschel M; Fava M
    Life Sci; 1981 Jul; 29(2):121-33. PubMed ID: 6270486
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible decrease in dopaminergic 3H-agonist binding after 6-hydroxydopamine and irreversible decrease after kainic acid.
    Schweitzer BI; Bacopoulos NG
    Life Sci; 1983 Jan; 32(5):531-40. PubMed ID: 6296593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of [3H]apomorphine to an aporphine binding site as well as to dopamine sites in tissue from bovine caudate nucleus.
    Arana GW; Lamont JS; Baldessarini RJ; Teicher MH; Neumeyer JL; Cohen BM
    Neuropharmacology; 1984 Aug; 23(8):885-92. PubMed ID: 6483116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
    Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
    Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of [3H]apomorphine binding to bovine brain tissue.
    Arana GW; Baldessarini RJ; Harding M
    Biochem Pharmacol; 1981 Dec; 30(23):3171-9. PubMed ID: 7317102
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.
    Camus A; Javoy-Agid F; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of apomorphine on rat brain opiate receptors].
    Morozov GV; Panchenko LF; Anokhina IP; Balashov AM; Vekshina NL
    Biull Eksp Biol Med; 1980 Nov; 90(11):566-8. PubMed ID: 6256025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opiate receptor.
    Simantov R; Snyder SH
    Biochem Soc Trans; 1977; 5(1):62-5. PubMed ID: 196964
    [No Abstract]   [Full Text] [Related]  

  • 11. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
    List SJ; Seeman P
    J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.
    de Costa BR; Bowen WD; Hellewell SB; Walker JM; Thurkauf A; Jacobson AE; Rice KC
    FEBS Lett; 1989 Jul; 251(1-2):53-8. PubMed ID: 2568952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites.
    Agnati LF; Fuxe K; Benfenati F; Battistini N
    Acta Physiol Scand; 1983 Dec; 119(4):459-61. PubMed ID: 6320589
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 18. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3H-Apomorphine interactions with dopamine receptors in calf brain.
    Thal L; Creese I; Snyder SH
    Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.